Langvarig behandling (mindst 48 uger) Andelen af patienter, som havde klinisk signifikante bivirkninger i form af vægtøgning, glucose, total/ LDL/ HDL kolesterol eller triglycerider, steg over tid.
Long-term exposure (at least 48 weeks) The proportion of patients who had adverse, clinically significant changes in weight gain, glucose, total/ LDL/ HDL cholesterol or triglycerides increased over time.